COVID-19 And IP: Companies Are 'Taking A Chance' Sharing Clinical Trial Details

 
• By Brenda Sandburg

While companies often keep clinical trial endpoints a secret, FDA's Peter Marks notes that may not be the case with COVID-19 vaccines; CDER's Patrizia Cavazzoni says agency may expand de-centralized trials.

Business, Technology, Internet and network concept. Young businessman working on a virtual screen of the future and sees the inscription: Clinical trial
COVID-19 vaccine developers may share clinical trial data

More from Clinical Trials

More from R&D